Theravance Biopharma (TBPH) EPS (Basic) (2013 - 2026)
Theravance Biopharma's (TBPH) quarterly EPS (Basic) came in at -$0.1 in Q1 2026, up 64.52% year-on-year from -$0.06 in Q1 2025, and down 117.02% on a QoQ basis from $0.57 in Q4 2025.
Theravance Biopharma (TBPH) EPS (Basic) (2013 - 2026) Analysis & Trends
Theravance Biopharma (TBPH) has 14 years of EPS (Basic) data on file, last reported at -$0.1 in Q1 2026.
- On a quarterly basis, EPS (Basic) rose 64.52% year-over-year to -$0.1 in Q1 2026; TTM through Mar 2026 was $1.6, a 236.47% increase from a year earlier, with the FY2025 full-year figure at $1.39, up 220.6% from the prior year.
- EPS (Basic) for Q1 2026 stood at -$0.1, down from $0.57 in the prior quarter.
- Over the last five years, EPS (Basic) for TBPH reached as high as $12.28 in Q3 2022 and fell as low as -$0.34 in Q1 2023.
- Historically, EPS (Basic) has averaged $0.71 across 5 years, with a median of -$0.1 in 2026.
- Across the five-year window, EPS (Basic) surged 4284.34% in 2022 and tumbled 281.22% in 2023, its largest moves.
- Year by year, EPS (Basic) stood at $0.05 in 2022, then tumbled by 281.22% to -$0.1 in 2023, then slumped by 231.49% to -$0.32 in 2024, then jumped by 279.11% to $0.57 in 2025, then plunged by 117.02% to -$0.1 in 2026.
- Per Business Quant data, the three most recent EPS (Basic) figures were -$0.1 in Q1 2026, $0.57 in Q4 2025, and $0.07 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 0.00 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 0.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 0.16 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 4.06 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 6.99 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | 0.00 |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 5.90 |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -2.29 |
| 10 | Theravance Biopharma | 864.82 Mn | 470.15 Mn | - | -0.10 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.10 |
| Dec 31, 2025 | 0.57 |
| Sep 30, 2025 | 0.07 |
| Jun 30, 2025 | 1.09 |
| Mar 31, 2025 | -0.27 |
| Dec 31, 2024 | -0.32 |
| Sep 30, 2024 | -0.26 |
| Jun 30, 2024 | -0.34 |
| Mar 31, 2024 | -0.24 |
| Dec 31, 2023 | -0.10 |
| Sep 30, 2023 | -0.17 |
| Jun 30, 2023 | -0.28 |
| Mar 31, 2023 | -0.34 |
| Dec 31, 2022 | 0.05 |
| Sep 30, 2022 | 12.28 |
| Jun 30, 2022 | 0.24 |
| Mar 31, 2022 | 0.21 |
| Dec 31, 2021 | 0.37 |
| Sep 30, 2021 | 0.28 |
| Jun 30, 2021 | 0.19 |